研究目的
To develop a three-dimensional visualization method for evaluating the distribution of pulmonary drug delivery systems and compare four tissue-clearing techniques (ClearT2, CUBIC, ScaleS, and SeeDB2) using intrapulmonary liposomes as drug carriers.
研究成果
The ClearT2 tissue-clearing technique is considered appropriate for the 3D visualization of intrapulmonary liposomes as a model pulmonary drug delivery system at the alveolar scale, based on clearing capability, treatment times, preservation of fluorescent probes, and stability of liposomes. This study provides important information for selecting and optimizing suitable optical tissue-clearing techniques in the lungs for evaluating the distribution of pulmonary drug delivery systems.
研究不足
The 3D imaging can only be obtained at a small scale. There is no quantitative measure, as results are given in arbitrary fluorescence units. In addition, fluorescent probe can affect the result. It would be difficult to apply this technique to larger animal models.
1:Experimental Design and Method Selection:
The study compared four aqueous solution-based tissue-clearing techniques (ClearT2, CUBIC, ScaleS, SeeDB2) for 3D visualization of liposome distribution in mouse lungs. Protocols followed standard methods from literature, involving refractive index matching or hyperhydration mechanisms.
2:Sample Selection and Data Sources:
Male ICR mice (6 weeks old, 26–28 g) were used. Lung samples were prepared by intrapulmonary administration of fluorescent probes (e.g., rhodamine B-labeled liposomes, Texas Red dextran) and intravenous administration of DyLight-conjugated tomato lectin, followed by fixation with paraformaldehyde.
3:List of Experimental Equipment and Materials:
Equipment included a Liquid MicroSprayer? (Model IA-1C, PennCentury, Inc.), laser-scanning confocal microscope (LSM 700, Zeiss), fluorescence zoom microscope (Axio Zoom.V16, Zeiss), microplate reader (Powerscan HT, DS Pharma Biomedical), and Zetasizer Nano ZS (Malvern Instruments Ltd.). Materials included lipids (HEPC, DSPE-PEG2000, DPPE, cholesterol, DCP), fluorescent probes (rhodamine B-DPPE, DiI, DiD, FITC-dextran, Texas Red dextran, DyLight-conjugated tomato lectin), and clearing reagents (e.g., formamide, glycerol, urea, Triton X-100).
4:0). Experimental Procedures and Operational Workflow:
4. Experimental Procedures and Operational Workflow: Mice were administered probes via MicroSprayer or intravenous injection, perfused and fixed with paraformaldehyde, then subjected to tissue-clearing treatments per standard protocols. Clearing was assessed via microscopy, and 3D images were reconstructed from confocal stacks. Liposome stability was tested by incubating FITC-dextran-encapsulated liposomes in clearing reagents and measuring release.
5:Data Analysis Methods:
Fluorescence intensity was measured with a microplate reader, and images were analyzed using confocal microscopy for depth and distribution. Statistical analysis included mean ± SD calculations for multiple replicates.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容-
Laser-scanning confocal microscope
LSM 700
Zeiss
Observation and 3D visualization of cleared lung tissues and fluorescent probes
ZEISS LSM 990 Spectral Multiplex
立即获取同款设备 -
Fluorescence zoom microscope
Axio Zoom.V16
Zeiss
Macroscopic visualization of DiI on lung lobes after tissue-clearing treatment
暂无现货
预约到货通知
-
Zetasizer
Nano ZS
Malvern Instruments Ltd.
Determination of particle sizes and zeta potential of liposomes
暂无现货
预约到货通知
-
Liquid MicroSprayer
Model IA-1C
PennCentury, Inc.
Administration of liposomes and fluorescent probes intrapulmonarily to mice
暂无现货
预约到货通知
-
Microplate reader
Powerscan HT
DS Pharma Biomedical
Measurement of fluorescence intensity of fluorescent probes in clearing reagents
暂无现货
预约到货通知
-
Polycarbonate filters
Nuclepore
Whatman
Extrusion of liposomes through filters with pore sizes of 1000, 400, and 100 nm
暂无现货
预约到货通知
-
Size exclusion column
Sepharose CL 4B
GE Healthcare Ltd.
Elution of liposomes to remove non-encapsulated FITC-dextran
暂无现货
预约到货通知
-
登录查看剩余5件设备及参数对照表
查看全部